amikacin has been researched along with tigecycline in 86 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 24 (27.91) | 29.6817 |
| 2010's | 47 (54.65) | 24.3611 |
| 2020's | 15 (17.44) | 2.80 |
| Authors | Studies |
|---|---|
| Fulcher, LC; Griffith, ME; Hawley, JS; Hospenthal, DR; Jorgensen, JH; McElmeel, ML; Murray, CK | 1 |
| Bouza, E; Cercenado, E; Cuevas, O; Marín, M; Martínez-Alarcón, J; Sánchez-Martínez, M | 1 |
| Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV | 1 |
| Noskin, GA; Obias, A; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, T | 1 |
| Carmeli, Y; Chmelnitsky, I; Leavitt, A; Navon-Venezia, S; Schwaber, MJ | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
| Castanheira, M; Deshpande, LM; Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Craft, DW; Hachmeister, L; Hong, SG; Kim, SY; Moland, ES; Sayed, SD; Thomson, KS | 1 |
| Bratu, S; Georgescu, C; Landman, D; Martin, DA; Quale, J | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P | 1 |
| Della-Latta, P; Dib-Hajj, F; Dougherty, BA; Gootz, TD; He, W; Huard, RC; Lescoe, MK | 1 |
| Jones, RN; Leonard, SN; Rybak, MJ; Sader, HS; Vidaillac, C | 1 |
| Capone, A; D'Andrea, MM; D'Arezzo, S; Giani, T; Luzzaro, F; Petrosillo, N; Rossolini, GM; Visca, P | 1 |
| Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U | 1 |
| Du, X; Ji, S; Jiang, Y; Li, L; Shen, P; Wei, Z; Yu, Y | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Brémont, S; Courvalin, P; Daurel, C; Fiant, AL; Leclercq, R | 1 |
| Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Aquino, EE; León, CF; Otero, DM; Robledo, IE; Santana, JL; Santé, MI; Vázquez, GJ | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Leavitt, A; Navon-Venezia, S; Ofek, I | 1 |
| Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK | 1 |
| Jiang, Y; Shen, P; Wei, Z; Yu, D; Yu, Y; Zhou, Z | 1 |
| Aggen, JB; Armstrong, ES; Diokno, R; Dozzo, P; Feeney, LA; Gliedt, MJ; Goldblum, AA; Gomez, M; Hildebrandt, DJ; Kubo, A; Linsell, MS; Lopez, S; Matias, RD; Miller, GH; Moser, HE; Wlasichuk, KB | 1 |
| Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, CL; Clark, RB; Deng, Y; Fyfe, C; Grossman, TH; He, M; Hunt, DK; Sun, C; Sutcliffe, JA; Xiao, XY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, CL; Deng, Y; Fyfe, C; Grossman, TH; Hunt, DK; Sun, C; Sutcliffe, JA; Xiao, XY | 1 |
| Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D | 1 |
| Petrini, B | 1 |
| Balada-Llasat, JM; Bannerman, T; Biller, B; Gebreyes, WA; Mangino, JE; Pancholi, P; Sopirala, MM | 1 |
| Hur, J; Kim, HS; Lee, KM; Park, MJ; Park, MS; Song, W; Woo, H; Yim, H | 1 |
| Bonne, S; Legout, L; Prevotat, A; Senneville, E; Veziris, N; Yazdanpanah, Y | 1 |
| Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY | 1 |
| Dowzicky, MJ; Fernández-Canigia, L | 1 |
| Chen, JH; Hu, ST; Huang, CC; Huang, CW; Huang, WC; Lee, YC; Shen, GH | 1 |
| Carter, ER; Iwanaga, K | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L | 1 |
| Rajamohan, G; Srinivasan, VB; Vaidyanathan, V | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
| Chen, CC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Lai, CC; Tang, HJ; Toh, HS; Weng, TC; Yu, WL; Zhang, CC | 1 |
| Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
| Cai, Y; Chan, EC; Hong, Y; Hsu, LY; Koh, TH; Kwa, AL; Lee, W; Lim, TP; Sasikala, S; Tan, TT; Tan, TY; Teo, J | 1 |
| Gil-Romero, Y; Gómez-Garcés, JL; Merino, F; Vazquez, O | 1 |
| Chen, CC; Chuang, YC; Huang, HL; Lai, CC; Tang, HJ | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
| Costa, SF; de Castro Lima, VA; de Maio Carrillho, CM; de Oliveira, LM; Gaudereto, JJ; Levin, AS; Martins, RC; Perozin, JS; Urbano, MR | 1 |
| Alkan, G; Emiroglu, M; Turk Dagi, H | 1 |
| Aires, CA; Albano, RM; Asensi, MD; Buonora, SN; Carvalho-Assef, AP; Chagas, TP; de Araujo, CF; Oliveira, JC; Pereira, PS | 1 |
| Chesnel, L; Howland, K; Jacqueline, C | 1 |
| Li, Y; Liu, J; Liu, XJ; Lyu, Y; Xue, F | 1 |
| Lu, J; Pang, Y; Song, Y; Zhang, Z | 1 |
| Chen, NY; Chiu, CH; Chung, WH; Kuo, AJ; Lai, HC; Lee, MC; Liu, TP; Lu, JJ; Sun, PL; Wang, LH; Wu, TL; Wu, TS; Yang, CH; Yang, JH | 1 |
| Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
| Barkan, D; Grosfeld, T; Meir, M | 1 |
| Kadiri, NP; Mannelli, VK; Nemakayala, DR; Rai, MP | 1 |
| Decousser, JW; Dowzicky, MJ; Fines-Guyon, M; Soussy, CJ; Woerther, PL | 1 |
| Baba, S; Fukuoka, K; Horikoshi, Y; Kamada, K; Kanemaru, A; Kikuchi, K; Myojin, S; Okamoto, Y; Suzuki, H; Yoshida, A | 1 |
| Boix Boix, AS; Brandariz Núñez, D; Gurri Hernand, FJ; Hernández Corredoira, V; Puig Forcada, J; Rodríguez Pedreira, P | 1 |
| Çağ, Y; Can, F; Ergonul, O; Hacıseyitoğlu, D; Işık, ME; Menekşe, Ş; Şahin, S | 1 |
| Ko, WC; Stone, GG | 1 |
| Edwards, TA; Nicholson, D; O'Neill, AJ; Ranson, NA | 1 |
| Bonet-Rossinyol, Q; Fernández-Pittol, M; Gonzalez-Martin, J; López-Gavín, A; Portell-Buj, E; Roman, A; Tudó, G | 1 |
| Piérard, D; Stone, GG | 1 |
| Feng, H; He, L; Wu, H; Xu, P; Zhang, H | 1 |
| Bai, Y; Cui, J; Wang, F; Yang, X; Zhou, Q | 1 |
| Chen, CH; Chen, NY; Chiu, CH; Chung, WH; Lai, HC; Lao, CK; Lee, CH; Liu, TP; Lu, JJ; Tseng, MC; Wu, TS; Yang, LY | 1 |
| Li, J; Liu, Y; Wang, H; Wu, G; Xu, X | 1 |
| Blondeau, J; Lucaßen, K; Seifert, H; Utt, EA | 1 |
| Bennett, JW; Corey, BW; Doi, Y; Iovleva, A; Kwak, YI; Lebreton, F; Luo, TL; McElheny, CL; McGann, PT; Preston, LN; Snesrud, E | 1 |
| Ammerman, NC; Bax, HI; de Steenwinkel, JEM; de Vogel, CP; Mudde, SE; Schildkraut, JA; van Ingen, J | 1 |
| Fang, W; Liu, W; Song, L; Sun, W; Wang, C | 1 |
| Chen, Y; Luo, H; Xu, L | 1 |
| Abad, L; Aull, HA; Cristinziano, M; Dedrick, RM; Hatfull, GF; Kaganovsky, AM; Loebinger, MR; Morkowska, A; Murthy, S; Satta, G; Smith, BE; Storey, N | 1 |
| Abdellatif, GR; Aboshanab, KM; Mabrouk, SS; Zaid, ASA | 1 |
3 review(s) available for amikacin and tigecycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Drug resistance and susceptibility of amikacin in children with extended-spectrum beta-lactamase-producing Enterobacterales: a systematic review with meta-analysis.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Child; Drug Resistance; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tigecycline | 2023 |
83 other study(ies) available for amikacin and tigecycline
| Article | Year |
|---|---|
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Military Personnel; Minocycline; Polymyxin B; United States; Warfare | 2007 |
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2007 |
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2007 |
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Infective Agents; Carbapenems; Drug Combinations; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2007 |
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Latin America; Microbial Sensitivity Tests; Minocycline; North America; Population Surveillance; Tigecycline | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Endemic Diseases; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; New York City; Sequence Analysis, DNA | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans | 2008 |
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Hospitals, Urban; Humans; Isoenzymes; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Plasmids; Transposases | 2009 |
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Genotype; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Sequence Analysis, DNA | 2009 |
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland | 2009 |
Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacter; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Tigecycline | 2009 |
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Detection of KPC in Acinetobacter spp. in Puerto Rico.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Puerto Rico | 2010 |
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors | 2010 |
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Plasmids; Polymerase Chain Reaction | 2010 |
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan | 2010 |
Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Klebsiella pneumoniae; Models, Genetic; Molecular Sequence Data; Plasmids | 2010 |
Synthesis and spectrum of the neoglycoside ACHN-490.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Enterobacteriaceae; Microbial Sensitivity Tests; Molecular Structure; Proteus mirabilis; Pseudomonas aeruginosa; Sisomicin | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Drug Design; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship; Tetracyclines; Thigh | 2015 |
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Halogenation; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrrolidinones; Tetracycline Resistance; Tetracyclines | 2017 |
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline | 2019 |
Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Topics: Amikacin; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2011 |
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline | 2011 |
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline | 2012 |
Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter; Escherichia coli; Imipenem; Klebsiella oxytoca; Klebsiella pneumoniae; Latin America; Meropenem; Microbial Sensitivity Tests; Minocycline; Serratia marcescens; Thienamycins; Tigecycline; United States; United States Food and Drug Administration | 2012 |
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Taiwan; Tigecycline | 2013 |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy.
Topics: Amikacin; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Child, Preschool; Clarithromycin; Female; Humans; Laryngostenosis; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline; Tomography, X-Ray Computed; Tracheostomy; Tuberculosis, Pulmonary | 2014 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline | 2013 |
AbuO, a TolC-like outer membrane protein of Acinetobacter baumannii, is involved in antimicrobial and oxidative stress resistance.
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carbenicillin; Membrane Transport Proteins; Minocycline; Oxidative Stress; Streptomycin; Tigecycline | 2015 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; DNA, Bacterial; Doxycycline; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Genotype; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2019 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Combinations; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacter cloacae; Gene Expression; Humans; Meropenem; Microbial Sensitivity Tests; Minocycline; Models, Statistical; Polymyxin B; Thienamycins; Tigecycline | 2016 |
[Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colonic Diseases; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Hernia, Abdominal; Herniorrhaphy; Humans; Intestinal Fistula; Minocycline; Postoperative Complications; Prosthesis-Related Infections; Soft Tissue Infections; Surgical Mesh; Tigecycline | 2017 |
The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.
Topics: Amikacin; Anti-Bacterial Agents; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; In Vitro Techniques; Minocycline; Tigecycline | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia; Prospective Studies; Soft Tissue Infections; Tigecycline; Urinary Tract Infections | 2017 |
Tigecycline Therapy in an Infant for Ventriculoperitoneal Shunt Meningitis.
Topics: Amikacin; Drug Therapy, Combination; Humans; Hydrocephalus; Infant; Infant, Premature, Diseases; Infusions, Intravenous; Injections, Spinal; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Minocycline; Off-Label Use; Salvage Therapy; Thienamycins; Tigecycline; Ventriculoperitoneal Shunt | 2017 |
Multiclonal Expansion of Klebsiella pneumoniae Isolates Producing NDM-1 in Rio de Janeiro, Brazil.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Brazil; Clone Cells; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Gene Expression; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymyxin B; Tigecycline | 2017 |
In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents.
Topics: Amikacin; Aztreonam; Cephalosporins; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Tazobactam; Tigecycline | 2017 |
Trends in Antimicrobial Resistance against Enterobacteriaceae Strains Isolated from Blood: A 10-year Epidemiological Study in Mainland China (2004-2014).
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2017 |
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan; Tertiary Care Centers; Tigecycline | 2017 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
Topics: Amikacin; Animals; Larva; Levofloxacin; Linezolid; Meropenem; Moths; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Azithromycin; Drug Resistance, Multiple, Bacterial; Hip Joint; Humans; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tigecycline | 2018 |
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Levofloxacin; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae; Tigecycline; Vancomycin | 2018 |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
Topics: Amikacin; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Otitis Media; Tigecycline; Tokyo | 2018 |
[Septic shock secondary to Elizabethkingia meningoseptica: A case report].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Chryseobacterium; Drug Therapy, Combination; Flavobacteriaceae Infections; Humans; Male; Meropenem; Rifampin; Shock, Septic; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tigecycline; Young Adult | 2019 |
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
Topics: Amikacin; Anti-Bacterial Agents; Asia; Australia; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2020 |
Structure of the 70S Ribosome from the Human Pathogen Acinetobacter baumannii in Complex with Clinically Relevant Antibiotics.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Binding Sites; Cryoelectron Microscopy; Models, Molecular; Ribosome Subunits; Ribosomes; Tigecycline | 2020 |
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2021 |
In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Citrobacter koseri; Colistin; Drug Combinations; Enterobacteriaceae; Epidemiological Monitoring; Escherichia coli; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tigecycline | 2021 |
In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Tigecycline | 2021 |
Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline; Time Factors | 2021 |
Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Humans; Imipenem; Immunosuppressive Agents; Linezolid; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Taiwan; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Central Nervous System Infections; Cerebral Ventriculitis; Encephalitis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Tigecycline | 2022 |
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Colistin; Gram-Negative Bacteria; Levofloxacin; Meropenem; Phenotype; Tigecycline | 2022 |
IS
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Persistent Infection; Plasmids; RNA, Ribosomal, 16S; Tigecycline; Toxin-Antitoxin Systems | 2022 |
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Thioridazine; Tigecycline; Verapamil | 2022 |
Distribution of microbes and antimicrobial susceptibility in patients with diabetic foot infections in South China.
Topics: Amikacin; Anti-Bacterial Agents; Coinfection; Diabetes Mellitus; Diabetic Foot; Ertapenem; Gram-Negative Bacteria; Humans; Meropenem; Retrospective Studies; Tigecycline | 2023 |
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophages; Delivery of Health Care; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phylogeny; Tigecycline | 2023 |
Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin.
Topics: Amikacin; Carbapenems; Escherichia coli; Humans; Meropenem; Propranolol; Tigecycline | 2023 |